FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Perrigo Guaifenesin Grape liquid 100 mg/5 mL Recall

Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz

Perrigo Company PLC · Allegan, MI

Risk level
Class II
Reported by FDA
Feb 3, 2016
Recall ID
D-0586-2016
Check your lot numberHow we source this data

Summary

Perrigo recalled Guaifenesin Grape liquid 100 mg/5 mL starting Jan 8, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0586-2016 on Feb 3, 2016. Reason: Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups. Status: Terminated.

Why it was recalled

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Product description

Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under the following: a) H.E.B. Mucus Relief, Children's Guaifenesin, Expectorant, Age 4+, Grape Flavor, Gluten Free, Alcohol Free, 4 FL OZ (118 mL) Bottle, Made for: H.E.B. San Antonio, TX 78204, NDC 37808-288-26; b) CVS, Children's Mucus Relief Chest Congestion, Guaifenesin, Expectorant, Alcohol free, Gluten free, 4 FL OZ (118 mL) Bottle, For Ages 4 to 12 Years, Grape Flavor Liquid, Dosage Cup Included, Distributed by CVS Pharmacy Inc, One CVS Drive, Woonsocket, RI, 02895, NDC 59779-288-26.

Lot numbers, UPCs & expiration codes

Lot #s: 5MK0340, 5LK0592, Exp 08/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0586-2016
Classification
Class II
Status
Terminated
Recall initiated
Jan 8, 2016
FDA report date
Feb 3, 2016
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Perrigo Company PLC

Original FDA data

Every field from FDA enforcement report D-0586-2016, exactly as published.

Show all FDA fields
City
Allegan
State
MI
Status
Terminated
Country
United States
Event ID
73044
Address
515 Eastern Ave
Code information
Lot #s: 5MK0340, 5LK0592, Exp 08/17
Postal code
49010-9070
Report date
Feb 3, 2016
Product type
Drugs
Recall number
D-0586-2016
Classification
Class II
Recalling firm
Perrigo Company PLC
Termination date
May 18, 2016
Reason for recall
Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under the following: a) H.E.B. Mucus Relief, Children's Guaifenesin, Expectorant, Age 4+, Grape Flavor, Gluten Free, Alcohol Free, 4 FL OZ (118 mL) Bottle, Made for: H.E.B. San Antonio, TX 78204, NDC 37808-288-26; b) CVS, Children's Mucus Relief Chest Congestion, Guaifenesin, Expectorant, Alcohol free, Gluten free, 4 FL OZ (118 mL) Bottle, For Ages 4 to 12 Years, Grape Flavor Liquid, Dosage Cup Included, Distributed by CVS Pharmacy Inc, One CVS Drive, Woonsocket, RI, 02895, NDC 59779-288-26.
Distribution pattern
Nationwide
Recall initiation date
Jan 8, 2016
Initial firm notification
Letter
Center classification date
Jan 22, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0586-2016, published Feb 3, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls